Literature DB >> 8785882

Problem sites: scalp, palm and sole, and nail.

O Larko1.   

Abstract

The scalp, palms and soles, and nails are problem sites in the everyday therapy of psoriasis. This article reviews the pathogenesis, differential diagnosis, and latest treatment.

Entities:  

Mesh：

Year:  1995        PMID： 8785882

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN： 0733-8635            Impact factor:   3.478


  3 in total

1.  Efalizumab in the Treatment of Scalp, Palmoplantar and Nail Psoriasis: Results of a 24-Week Latin American Study.

Authors:  María Denise Takahashi; Edgardo Néstor Chouela; Gladys Leon Dorantes; Ana Maria Roselino; Jesùs Santamaria; Miguel Angel Allevato; Tania Cestari; Maria Eugenia Manzanera de Aillaud; Fernando Miguel Stengel; Daiana Licu
Journal:  Arch Drug Inf       Date:  2010-03

2.  Differences in Clinical Responses to Ustekinumab Treatment among Body Regions: Results from a Real-World Prospective, Observational, and Multi-Center Study in Korea.

Authors:  Sang Wook Son; Dae Young Yu; Youngdoe Kim; Hyo Hyun Ahn; Yong Hyun Jang; Joo Young Roh; Young Bok Lee; Ji Yeoun Lee; Myung Hwa Kim; YoungJa Lee; Gyeong-Hun Park; Hyun-Sun Yoon; Sang Woong Youn
Journal:  Ann Dermatol       Date:  2022-01-27       Impact factor: 1.444

3.  Assessing the Impact of Efalizumab on Nail, Scalp and Palmoplantar Psoriasis and on Quality of Life: Results from a Multicentre, Open-label, Phase IIIb/IV Trial.

Authors:  Andreas Katsambas; Ketty Peris; Gino Vena; Peter Freidmann; Gottfried Wozel; Esteban Daudén; Daiana Licu; Mauro Placchi; Michel De La Brassinne
Journal:  Arch Drug Inf       Date:  2009-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.